# 625 - P2 Validation and Audit

## Gate Result

P2 passed.

## Automated Validation

```text
python -m unittest discover -s tests -t .
Ran 214 tests
OK

bundled-node --check interfaces/web/static/app.js
OK

git diff --check
OK
```

## Clinical Safety Audit

- all six newly promoted safety domains require explicit assessment;
- missing values remain unknown and block;
- present delirium, intoxication, withdrawal, aggression, allergy or severe
  adverse reaction blocks routine strategy;
- source-anchored serious syndrome contexts block routine ranking;
- source-pending context entries do not create treatment behavior;
- unknown context identifiers are not silently accepted;
- toxidrome screening remains screening-only and non-diagnostic.

## Coverage Audit

- delirium, intoxication and withdrawal: explicit safety and registry coverage;
- extrapyramidal adverse syndromes: structural partial coverage, sources pending;
- serotonin syndrome and neuroleptic malignant syndrome: source-anchored
  screening coverage;
- alcohol, opioids, nicotine, benzodiazepines, stimulants, cocaine/crack,
  cannabis and hallucinogens: explicit contextual representation;
- neurocognitive, developmental and perinatal areas: explicit boundaries, not
  treatment modules.

## Architecture and Evidence Audit

- Application owns registry and blocking semantics;
- Interface receives only serialized registry metadata;
- no unsupported clinical content was promoted;
- response makes evidence and runtime status visible;
- physician responsibility and non-prescriptive operation remain unchanged.

## Residual Scientific Limitation

Several contexts remain `source_pending`. They are covered structurally but are
not certified as treatment knowledge. P3 must audit scientific review status
across pharmacological data before runtime eligibility can be certified.

## Declaration Final

P2 is complete and the program may proceed to P3.
